News

It has been nearly one year since SARS-COV-2 (COVID-19) changed the world. With millions of people infected and over a quarter-million dead in the United States (U.S.), the novel coronavirus continues its pervasive hold on our health and well-being.

“We have the expertise and equipment to advance testing procedures and understand more about the virus’ presence in wastewater—gaining knowledge that can help not only our local community, but also areas around the world that may lack testing infrastructure.”

Anyone over the age of 18 is invited to complete a short survey from Wellness, Health, & You (WHY), an ongoing research project that seeks to understand how different life experiences affect wellbeing and health.

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

Kelly G. Pennell, Gill Associate Professor in the Department of Civil Engineering and director of the UK Superfund Research Center (UK-SRC), has co-authored an article detailing lessons learned about stakeholder engagement and risk communication relevant for COVID-19 and school reopening.

Totaling more than $429 million, the University of Kentucky saw a record-breaking year of research funding for the 2019-20 academic year, a 3% increase from the previous year. UK also continues to climb in national research rankings.

The Prichard Committee Student Voice Team, in consultation with UK faculty members, set out to gauge how disruptions caused by the pandemic were impacting students’ academic motivation and learning, as well as their physical, social and emotional health.

“This study affirms notions that different practitioner groups experience, and are impact by, COVID-19 differently,” Miller said. “Therefore, cookie-cutter approaches to addressing challenges associated with COVID-19 distress may not be effective.” 

Markey has joined a consortium of 17 cancer centers across the country to better understand how COVID-19 has impacted cancer prevention, detection and care.

A new UK study may provide answers for why so many COVID-19 patients experience blood clotting – and why the risk of thrombosis could remain even after the infection clears.